Robert Bradway, Amgen CEO (Reuters/Stephen Lam)

Am­gen's CEO says he's 'con­fi­den­t' their $28B deal with Hori­zon can close de­spite FTC law­suit

A day af­ter fed­er­al an­titrust au­thor­i­ties sued to stop Am­gen’s $28 bil­lion takeover of Hori­zon Ther­a­peu­tics, Am­gen’s CEO said he still ex­pects the deal to close.

“We re­main ex­cit­ed about the prospect of this com­bi­na­tion,” Am­gen CEO Robert Brad­way said at an event host­ed by the Fi­nan­cial Times on Wednes­day in New York. (The FT owns a ma­jor­i­ty stake in End­points News, though the news or­ga­ni­za­tions are in­de­pen­dent.)

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.